Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 148 Results

Intervention Indication Therapeutic Area Year Actions
Abaloparatide for treating osteoporosis in males aged 40 to 85 years Abaloparatide (Tymlos; BA058) Osteoporosis Musculoskeletal System 2021 View  |  Download
Afamitresgene autoleucel for advanced synovial sarcoma or myxoid/round cell liposarcoma ADP-A2M4 (MAGE-A4 SPEAR T-cell) Soft tissue sarcoma , Synovial sarcoma Sarcoma 2021 View  |  Download
Amivantamab for advanced non-small-cell lung cancer Amivantamab (JNJ-6372; JNJ-61186372) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Atezolizumab for adjuvant treatment of squamous cell carcinoma of the head and neck Atezolizumab (Tecentriq; MPDL3280A) Head and neck cancer Head and Neck Cancer 2021 View  |  Download
Baloxavir marboxil for treating paediatric patients 1 to <12 years of age with influenza Baloxavir marboxil (Xofluza; S-033188) Influenza Infectious Disease 2021 View  |  Download
Baricitinib for systemic lupus erythematosus Baricitinib (LY3009104; Olumiant) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2021 View  |  Download
Baricitinib for treatment of severe alopecia areata in adults Baricitinib (LY3009104; Olumiant) Alopecia areata Dermatology , Immunology 2021 View  |  Download
Belimumab in combination with rituximab for systemic lupus erythematosus (SLE) Belimumab (Benlysta; Lymphostat-B) , Rituximab (MabThera; Rituxan; RG 105) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2021 View  |  Download
Belumosudil for graft versus host disease Belumosudil (SLx-2119; KD025; KD-025) Graft versus host disease (GvHD) Immunology 2021 View  |  Download
Belzutifan for von Hippel-Lindau disease-associated clear cell renal cell carcinoma – first line Belzutifan (PT2977; MK-6482) Renal cell carcinoma (RCC) Genetic Disorders , Oncology , Renal Cancer 2021 View  |  Download
1 2 3 14 15
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications